Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

ASCO 2009 - Testicular Cancer Session Highlights
ASCO 2009 - High-Dose Chemotherapy as Second Salvage Treatment in Patients with Multiple Relapsed or Refractory Germ Cell Tumors - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The purpose of this study was to determine the role of high-dose chemotherapy (HDCT) as secondary salvage treatment in patients with relapsed germ-cell tumors (GCT).
Login to read more...

ASCO 2009 - Individualized Intensification of Treatment Based on Tumor Marker Decline in Metastatic Nonseminomatous Germ Cell Testicular Cancer: A Report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The authors presented results from a large population-based multicenter study which individualized intensification of treatment based on tumor marker response in patients with metastatic nonseminomatous germ-cell tumors (NSGTS).
Login to read more...

ASCO 2009 - Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ-Cell Tumors: Updated Analysis of a Randomized Trial with 8 years Follow-up - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The authors presented an updated analysis from their randomized trial of 3 cycles of BEP chemotherapy vs. 4 cycles of BEP chemotherapy for good-prognosis testicular cancer.
Login to read more...

ASCO 2009 - Clinical Problems in Oncology: Challenging Cases in Nonseminomatous Germ Cell Tumors - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - This session was comprised of a panel discussion between Drs. Craig Nichols, Richard Foster and Charles Ryan.
Login to read more...

ASCO 2009 - On the Necessity for Postchemotherapy Surgery for Residual Abdominal Masses in Metastatic Nonseminomatous Germ Cell Tumors (NSGCT) of Testis - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - RPLND is classically performed in patients with nonseminomatous germ-cell tumors (NSGCTs) who demonstrate a residual mass following chemotherapy.
Login to read more...

 
<< Start < Prev 1 Next > End >>
Results 1 - 5 of 5
back

UroToday, 1802 Fifth Street, Berkeley CA 94710
510.540.0930 (fax), info@urotoday.com
ISSN 1939-4810
About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use


Privacy Policy | © 2009 UroToday ® All Rights Reserved

Member's Section

Login

Sign Up

Quick Search


Advanced Search

Meet the Expert


All Experts


Featured Conference

Working with Industry

Case Studies
Sponsorship Opportunities

Conference Reports
Sponsored By